Clinical trials of immunotherapy in triple-negative breast cancer Frederick M. HowardAlexander T. PearsonRita Nanda Review Open access 14 July 2022 Pages: 1 - 15
Intratumoral PDGFB gene predominantly expressed in endothelial cells is associated with angiogenesis and lymphangiogenesis, but not with metastasis in breast cancer Rongrong WuShipra GandhiKazuaki Takabe Preclinical study 06 July 2022 Pages: 17 - 31
Prediction of breast cancer-related lymphedema by dermal backflow detected with near-infrared fluorescence lymphatic imaging Melissa B. AldrichJohn C. RasmussenSimona F. Shaitelman Clinical trial Open access 10 July 2022 Pages: 33 - 41
Long-term dietary intervention influence on physical activity in the Women’s Health Initiative Dietary Modification randomized trial Kathy PanAaron K. AragakiRowan T. Chlebowski Clinical trial 12 July 2022 Pages: 43 - 54
nextMONARCH Phase 2 randomized clinical trial: overall survival analysis of abemaciclib monotherapy or in combination with tamoxifen in patients with endocrine-refractory HR + , HER2– metastatic breast cancer Erika HamiltonJavier CortesMiguel Martin Clinical trial Open access 12 July 2022 Pages: 55 - 64
Factors affecting inter-individual variability in endoxifen concentrations in patients with breast cancer: results from the prospective TOTAM trial C. Louwrens BraalJustin D. WestenbergRon H. J. Mathijssen Clinical trial Open access 16 July 2022 Pages: 65 - 74
Incidence of other cancer diagnoses in women with breast cancer: a retrospective cohort study with 42,248 women Ivan NikolovKarel KostevMatthias Kalder Epidemiology 12 July 2022 Pages: 75 - 82
Using menopause status and 21-gene expression assay to inform chemotherapy benefit in node-positive breast cancer Matthew G. DaveyMichael J. Kerin Letter to the Editor Open access 10 July 2022 Pages: 83 - 84
